Volume 95 Issue 20 | p. 15 | News of The Week
Issue Date: May 15, 2017 | Web Date: May 10, 2017

DSM invests $25 million in Amyris

Funds will be used to develop new routes to vitamins, pay down debt
Department: Business
Keywords: biobased chemicals, nutrition, vitamins, rubber

DSM will invest $25 million in the biobased chemicals firm Amyris and may follow with an additional $25 million in funding. DSM says Amyris’s fermentation technology is a good fit for its health, nutrition, and materials businesses, where consumers want products made from sustainable sources.

In the near-term, the two firms will work on health-related products, particularly vitamins and nutritional ingredients. They have an exclusive agreement to develop a low-cost route to vitamin A, which . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society